Prediction and prevention of recurrent spontaneous preterm birth.
暂无分享,去创建一个
[1] S. Cnattingius,et al. The influence of gestational age and smoking habits on the risk of subsequent preterm deliveries. , 1999, The New England journal of medicine.
[2] C. Hobel,et al. The West Los Angeles Preterm Birth Prevention Project. I. Program impact on high-risk women , 1994 .
[3] B. Sibai,et al. Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. , 2001, JAMA.
[4] B. Mercer,et al. Impact of weight loss between pregnancies on recurrent preterm birth. , 2005, American journal of obstetrics and gynecology.
[5] R. Carr-Hill,et al. The repetition of spontaneous preterm labour. , 1986, British journal of obstetrics and gynaecology.
[6] M. Dombrowski,et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 1999, American journal of obstetrics and gynecology.
[7] W. Callaghan,et al. Estimated Effect of 17 Alpha-Hydroxyprogesterone Caproate on Preterm Birth in the United States , 2005, Obstetrics and gynecology.
[8] J. Schardein. Congenital abnormalities and hormones during pregnancy: a clinical review. , 1980, Teratology.
[9] V. Berghella,et al. Cerclage for prevention of preterm birth in women with a short cervix found on transvaginal ultrasound examination: a randomized trial. , 2004, American journal of obstetrics and gynecology.
[10] G. Thurnau,et al. Are women with recurrent spontaneous preterm births different from those without such history? , 2006, American journal of obstetrics and gynecology.
[11] S. Kenyon,et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study , 2006, BJOG : an international journal of obstetrics and gynaecology.
[12] P. Brocklehurst,et al. Antibiotics for treating bacterial vaginosis in pregnancy. , 2003, The Cochrane database of systematic reviews.
[13] B. Sibai,et al. Randomized Clinical Trial of Metronidazole Plus Erythromycin to Prevent Spontaneous Preterm Delivery in Fetal Fibronectin–Positive Women , 2003, Obstetrics and gynecology.
[14] J. Iams,et al. Prediction and early detection of preterm labor. , 2003, Obstetrics and gynecology.
[15] Brett A. Collins,et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. , 2001, The New England journal of medicine.
[16] C. Ananth,et al. Recurrence of spontaneous versus medically indicated preterm birth. , 2006, American journal of obstetrics and gynecology.
[17] P. Seed,et al. TOCOX—A randomised, double‐blind, placebo‐controlled trial of rofecoxib (a COX‐2‐specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk , 2005, BJOG : an international journal of obstetrics and gynaecology.
[18] J. Pell,et al. Interpregnancy interval and risk of preterm birth and neonatal death: retrospective cohort study , 2003, BMJ : British Medical Journal.
[19] V. Berghella,et al. Cerclage for Short Cervix on Ultrasonography: Meta-Analysis of Trials Using Individual Patient-Level Data , 2005, Obstetrics and gynecology.
[20] A. Kaider,et al. Cervicovaginal fetal fibronectin as a marker for preterm delivery: a meta-analysis. , 1999, American journal of obstetrics and gynecology.
[21] B. Sibai,et al. Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm delivery. , 2005, American journal of obstetrics and gynecology.
[22] M. Zugaib,et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. , 2003, American journal of obstetrics and gynecology.
[23] P. Brocklehurst,et al. Antibiotics for treating bacterial vaginosis in pregnancy. , 2005, The Cochrane database of systematic reviews.
[24] G. Visser,et al. The effects of 3g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension , 1995, British journal of obstetrics and gynaecology.
[25] S. F. Olsen,et al. Randomised clinical trials of fish oil supplementation in high risk pregnancies , 2000, BJOG : an international journal of obstetrics and gynaecology.
[26] Bernard Rosner,et al. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976 , 1997, BMJ.
[27] R. P. Heine,et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. , 2003, The New England journal of medicine.
[28] E. Fuentes-Afflick,et al. Interpregnancy Interval and the Risk of Premature Infants , 2000, Obstetrics and gynecology.
[29] J. Martin,et al. Births: final data for 2004. , 2006, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[30] B. Sibai,et al. Second-Trimester Cervical Sonography: Features Other Than Cervical Length to Predict Spontaneous Preterm Birth , 2004, Obstetrics and gynecology.
[31] R. Lilford,et al. A randomized double blind placebo controlled trial of fish oil in high risk pregnancy , 1996 .
[32] F. Malone,et al. Quad Screen as a Predictor of Adverse Pregnancy Outcome , 2005, Obstetrics and gynecology.
[33] J. Hauth,et al. Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial. , 2006, American journal of obstetrics and gynecology.
[34] E. Waters,et al. Interventions for promoting smoking cessation during pregnancy. , 2000, The Cochrane database of systematic reviews.
[35] M. Keirse. Progestogen administration in pregnancy may prevent preterm delivery , 1990, British journal of obstetrics and gynaecology.
[36] I. Chalmers,et al. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists Multicentre Randomised Trial of Cervical Cerclage , 1993 .
[37] J. Hauth,et al. Second‐Trimester Cervical Ultrasound: Associations With Increased Risk for Recurrent Early Spontaneous Delivery , 2000, Obstetrics and gynecology.
[38] C. Salafia,et al. Histologic placental lesions in women with recurrent preterm delivery , 2005, Acta obstetricia et gynecologica Scandinavica.
[39] K. Leveno,et al. Recurrence of Preterm Birth in Singleton and Twin Pregnancies , 2001, Obstetrics and gynecology.
[40] A. Grant,et al. Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration , 1992, The Lancet.
[41] W. O'Fallon,et al. Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974. , 1985, Fertility and sterility.
[42] C. Cook,et al. The cervix as a predictor of preterm delivery in ‘at‐risk’ women , 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[43] J. Iams,et al. Rates of recurrent preterm birth by obstetrical history and cervical length. , 2005, American journal of obstetrics and gynecology.
[44] R. Lilford,et al. A randomised double blind placebo controlled trial of fish oil in high risk pregnancy , 1995, British journal of obstetrics and gynaecology.
[45] S F Bottoms,et al. The preterm prediction study: a clinical risk assessment system. , 1996, American journal of obstetrics and gynecology.
[46] J. Stockman. Birth Spacing and Risk of Adverse Perinatal Outcomes: A Meta-analysis , 2007 .
[47] B. Sibai,et al. Number and gestational age of prior preterm births does not modify the predictive value of a short cervix. , 2004, American journal of obstetrics and gynecology.
[48] J. Horan,et al. Effect of the interval between pregnancies on perinatal outcomes. , 1999, The New England journal of medicine.
[49] H. Wilson,et al. Rates of and factors associated with recurrence of preterm delivery. , 2000, JAMA.
[50] M. Dombrowski,et al. The Preterm Prediction Study: toward a multiple-marker test for spontaneous preterm birth. , 2001, American journal of obstetrics and gynecology.
[51] Acog. ACOG Committee on Obstetric Practice Number 291, November 2003: Use of Progesterone to Reduce Preterm Birth , 2003 .
[52] J. Langhoff‐Roos,et al. Implications of Idiopathic Preterm Delivery for Previous and Subsequent Pregnancies , 1995, Obstetrics and gynecology.
[53] S F Bottoms,et al. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. , 1998, American journal of public health.
[54] F. Malone,et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). , 2004, American journal of obstetrics and gynecology.